Subjects: DIABETES; DRUGS; ANESTHESIAELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY
Record details
Subjects: *QUARTERLY reports; *STOCK prices; *STOCKS (Finance)ELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY
Subjects: *PHARMACY benefit management; *REBATES; OBESITYELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLYBIDEN, Joe, 1942-
Subjects: *HIGH technology industries; INNER cities; DRUGSNOVO Nordisk A/S NOVO Nordisk A/S NOVO Nordisk A/S NVO; ELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY
Subjects: ANTIOBESITY agents; TYPE 2 diabetes; PREDIABETIC stateELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY
Subjects: INTESTINAL diseases; CHRONIC diseases; DRUGSELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY
Subjects: WEIGHT loss; OBESITY; DRUGSELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY
Subjects: ALZHEIMER'S disease; DRUGSUNITED States. Food & Drug Administration ; ELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY
Subjects: *SUPPLY & demand; ALZHEIMER'S disease; DRUGSELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY